Overview

A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab

Status:
Completed

Trial end date:
1997-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the effectiveness and safety of intracoronary stenting with or without abciximab, an anti-platelet therapy, and conventional coronary angioplasty with abciximab in patients undergoing percutaneous coronary intervention.

Phase:

Phase 3

Details

Lead Sponsor:

Centocor, Inc.

Treatments:

Abciximab
Antibodies, Monoclonal
Calcium heparin
Heparin
Immunoglobulin Fab Fragments